CD4 and neoplasm: More specifically, we estimated 28 immune cell types infiltrating and observed a lower proportion of tumor‐infiltrating lymphocytes (TILs) in the MS1 cohort (Figure 6A), including activated CD4+ T cells, natural killer T cells, type 2 T helper cells, and eosinophils.